Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Growth hormone and gonadotropin-releasing hormone analog therapy in haploinsufficiency of SHOX.

Endocrine journal - 1 Jun 2001

Ogata T, Onigata K, Hotsubo T, Matsuo N, Rappold G

Abstract excerpt

We report on GH (0.5 IU or 0.17 mg/kg/week) and GnRH analog (GnRHa, 60 microg/kg, every 4 weeks) therapy in SHOX haploinsufficiency. Case 1 was a 46,XY boy with microdeletion of the Y chromosomal pseudoautosomal region. At 7 years of age, he exhibited short stature (-3.9 SD) with a reduced growth...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Height
Share to Bone Diseases
Share to Gonadotropin-Releasing Hormone

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Growth Disorders

Share to Human Growth Hormone

Share to Puberty

Share to Short Stature Homeobox Protein

Share to Y Chromosome

Source

Identifiers

PMID: 11523902
DOI: 10.1507/endocrj.48.317

Genes

SHOX

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11523902-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Growth hormone and gonadotropin-releasing hormone analog therapy in haploinsufficiency of SHOX.PMID 11523902Read ↗

SHOX in short stature syndromes.Semantic proximity Read ↗

<i>SHOX</i> haploinsufficiency and overdosage: impact of gonadal function statusSemantic proximity Read ↗

Height outcome of the recombinant human growth hormone treatment in patients with SHOX gene haploinsufficiency: a meta-analysis.Semantic proximity Read ↗

Effectiveness of the Combined Recombinant Human Growth Hormone and Gonadotropin-Releasing Hormone Analog Therapy in Pubertal Patients with Short Stature due to<i>SHOX</i>DeficiencySemantic proximity Read ↗

[Short stature caused by SHOX gene haploinsufficiency: from diagnosis to treatment].Semantic proximity Read ↗

Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency.Semantic proximity Read ↗

Short stature due to SHOX deficiency: genotype, phenotype, and therapy.Semantic proximity Read ↗

Growth hormone therapy in patients with short stature homeobox-gene (SHOX) deficiency.Semantic proximity Read ↗

The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects.Semantic proximity Read ↗

Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.Semantic proximity Read ↗

The role of the SHOX gene in the pathophysiology of Turner syndrome.Semantic proximity Read ↗

Familial growth and skeletal features associated with SHOX haploinsufficiency.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.